Kennedy Trust for Rheumatology Research v Hospira Healthcare Corporation
2018
A-360-18
Resolved
Biosimilars
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd., Celltrion Inc. and Pfizer Canada Inc.
The decision is reported
here.
Meet the team
![Warren Sprigings](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b602718f3580ecb0cc1e_warren-bw-min.jpg)
Warren Sprigings
Partner